Sign up to save your podcasts
Or
Share An AI model for transplant risk in myelofibrosis; preventing priapism in men with sickle cell anemia; hallmarks of T cell exhaustion absent in newly diagnosed MM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
An AI model for transplant risk in myelofibrosis; preventing priapism in men with sickle cell anemia; hallmarks of T cell exhaustion absent in newly diagnosed MM
In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with sickle cell anemia. A recent phase 2 feasibility study shows high rates of recruitment, retention, and adherence to oral therapies, coupled with a significant reduction in the risk of this difficult complication. Finally, new research indicates that hallmarks of terminal T-cell exhaustion are absent in multiple myeloma, from diagnosis through maintenance therapy. We explore these provocative and counterintuitive findings arising from profiling of blood and marrow samples.
Featured Articles:
- Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
- A controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafil
- Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy
View all episodes
By American Society of Hematology
4.1
4848 ratings
In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with sickle cell anemia. A recent phase 2 feasibility study shows high rates of recruitment, retention, and adherence to oral therapies, coupled with a significant reduction in the risk of this difficult complication. Finally, new research indicates that hallmarks of terminal T-cell exhaustion are absent in multiple myeloma, from diagnosis through maintenance therapy. We explore these provocative and counterintuitive findings arising from profiling of blood and marrow samples.
Featured Articles:
- Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis
- A controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafil
- Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy
More shows like Blood Podcast
View all
JAMA Editors' Summary
133 Listeners
NEJM This Week
315 Listeners
The Hematologist
26 Listeners
JAMA Clinical Reviews
488 Listeners
JAMA Medical News
91 Listeners
Core IM | Internal Medicine Podcast
1,110 Listeners
VJHemOnc Podcast
3 Listeners
Annals On Call Podcast
191 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
The BSH Guidelines Official Podcast
1 Listeners
EHA Unplugged
1 Listeners
WolverHeme Happy Hour
28 Listeners
Two Onc Docs
169 Listeners
Blood Cancer Talks
49 Listeners
HemeTalks: Conversations in Hematology Education
3 Listeners